Evotec SE (EVO) Non-Current Assets (2009 - 2026)
Evotec SE's (EVO) quarterly Non-Current Assets came in at $982.3 million in Q2 2026, down 27.91% year-over-year from $1.4 billion in Q2 2025, and down 9.64% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Evotec SE (EVO) Non-Current Assets (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Assets across 9 years of filings, most recently posting $982.3 million for Q2 2026.
- In Q2 2026, Non-Current Assets fell 27.91% year-over-year to $982.3 million; the TTM figure through Jun 2026 stood at $982.3 million (down 27.91% YoY), while the FY2025 annual figure was $1.1 billion, down 19.33% from the prior year.
- Non-Current Assets came in at $982.3 million for Q2 2026 at Evotec SE, down from $1.1 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.5 billion in Q1 2024 to a low of $982.3 million in Q2 2026.
- Average Non-Current Assets over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2022.
- Year-over-year, Non-Current Assets climbed 20.23% in 2023 and dropped 27.91% in 2026.
- Over 5 years, Non-Current Assets stood at $1.2 billion in 2022, then advanced by 20.23% to $1.5 billion in 2023, then decreased by 9.42% to $1.3 billion in 2024, then fell by 15.81% to $1.1 billion in 2025, then retreated by 11.27% to $982.3 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $982.3 million in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 23.66 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.01 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 6.00 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 12.65 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 1.79 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 982.30 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 657.51 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 7.77 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 3.76 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 982.30 Mn |
| Mar 31, 2026 | 1.09 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 1.31 Bn |
| Sep 30, 2024 | 1.42 Bn |
| Mar 31, 2024 | 1.50 Bn |
| Dec 31, 2023 | 1.45 Bn |
| Jun 30, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.30 Bn |
| Sep 30, 2021 | 1.34 Bn |
| Dec 31, 2020 | 958.00 Mn |
| Sep 30, 2010 | 125.72 Mn |
| Jun 30, 2010 | 90.92 Mn |
| Mar 31, 2010 | 108,579.25 |